Global acceptance and hesitancy of COVID-19 vaccination: A narrative review

Wardah           Hassan; Syeda K.  Kazmi; Muhammad J.  Tahir; Irfan              Ullah; Hibban Ar  Royan; Marhami  Fahriani; Firzan  Nainu; Sandro GV. Rosa

doi:10.52225/narra.v1i3.57

Authors

Wardah Hassan Dow University of Health Sciences, Karachi, Pakistan https://orcid.org/0000-0002-0007-6756
Syeda K. Kazmi Dow University of Health Sciences, Karachi, Pakistan https://orcid.org/0000-0001-6386-6221
Muhammad J. Tahir Lahore General Hospital, Lahore, Pakistan; Ameer-ud-Din Medical College, Affiliated with University of Health and Sciences, Lahore, Pakistan https://orcid.org/0000-0002-0335-6681
Irfan Ullah Kabir Medical College, Gandhara University, Peshawar, Pakistan; Naseer Teaching Hospital, Peshawar, Pakistan https://orcid.org/0000-0003-1100-101X
Hibban Ar Royan Center for Indonesian Medical Students' Activities (CIMSA), Banda Aceh, Indonesia
Marhami Fahriani Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia
Firzan Nainu Faculty of Pharmacy, Hasanuddin University, Makassar, Sulawesi Selatan, Indonesia https://orcid.org/0000-0003-0989-4023
Sandro GV. Rosa Diretoria de Patentes, Divisão de Farmácia - Instituto Nacional da Propriedade Industrial, Rio de Janeiro, Brasil; Programa de Pós-Graduação em Ciências Aplicadas a Produtos para Saúde, Faculdade de Farmácia, Universidade Federal Fluminense, Brasil https://orcid.org/0000-0002-5644-7181

DOI:

https://doi.org/10.52225/narra.v1i3.57

Keywords:

COVID-19, COVID-19 vaccine, vaccination, vaccine acceptance, vaccine hesitancy

Abstract

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major global health threat to human civilization and has disrupted many aspects of the community around the globe. Vaccination is one of the prominent measures to control the COVID-19 pandemic. More than 120 vaccines have entered human clinical trials and at least 8 vaccines have been fully approved. However, the success of the COVID-19 vaccination programs depends on how the community accepts the vaccines. Despite COVID-19 vaccination having been initiated for a while now, more than 50% of the global population have not been vaccinated. In some low- and middle-income countries (LMICs), the vaccine coverage is less than 20%. Since the decision to accept the new vaccine is complex, understanding the factors underpinning vaccine acceptance is critical. This review aimed to summarize the COVID-19 vaccine acceptance rate around the globe as well as its associated determinants. Information from this study might be important to formulate effective strategies to increase the COVID-19 vaccine coverage, and to be able to achieve herd immunity.